SCHEMBL2419664

SCHEMBL2419664

CCOC1COCC[N]1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4912204 0.84
SCHEMBL4911927 0.81 SMN1; SMN2 (0.35)
SCHEMBL965233 0.76
SCHEMBL2411834 0.69
SCHEMBL10996644 0.68 TSHR (0.31)
SCHEMBL16141767 0.67
SCHEMBL5986940 0.67
SCHEMBL12734368 0.67
SCHEMBL1608120 0.67
SCHEMBL232762 0.67

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20190127413-A1 Compositions and Methods for Non-Toxic Delivery of Antiprogestins ALLERGAN PHARMACEUTICALS INTERNATIONAL LIMITED (IE) 2019-05-02 US claimed
EP-2550288-A1 COMPOSITIONS AND METHODS FOR NON-TOXIC DELIVERY OF ANTIPROGESTINS Repros Therapeutics Inc. (US) 2013-01-30 EP claimed
US-20130018027-A1 COMPOSITIONS AND METHODS FOR NON-TOXIC DELIVERY OF ANTIPROGESTINS REPROS THERAPEUTICS INC. (US) 2013-01-17 US claimed
WO-2011119194-A1 COMPOSITIONS AND METHODS FOR NON-TOXIC DELIVERY OF ANTIPROGESTINS REPROS THERAPEUTICS INC. (US) 2011-09-29 WO claimed
EP-3865502-A1 COMPOSITIONS AND METHODS FOR NON-TOXIC DELIVERY OF CDB-2914 Allergan Pharmaceuticals International Limited (IE) 2021-08-18 EP disclosed
US-20190127413-A1 Compositions and Methods for Non-Toxic Delivery of Antiprogestins ALLERGAN PHARMACEUTICALS INTERNATIONAL LIMITED (IE) 2019-05-02 US disclosed
US-20150203526-A1 NOVEL 19-NOR-STEROIDS AND THEIR USE FOR TREATING PROGESTERONE- DEPENDENT CONDITIONS REPROS THERAPEUTICS INC. (US) 2015-07-23 US disclosed
EP-2655394-A1 NOVEL 19-NOR-STEROIDS AND THEIR USE FOR TREATING PROGESTERONE-DEPENDENT CONDITIONS Repros Therapeutics Inc. (US) 2013-10-30 EP disclosed
US-20130274234-A1 NOVEL 19-NOR-STEROIDS AND THEIR USE FOR TREATING PROGESTERONE- DEPENDENT CONDITIONS REPROS THERAPEUTICS INC. (US) 2013-10-17 US disclosed
EP-2550288-A1 COMPOSITIONS AND METHODS FOR NON-TOXIC DELIVERY OF ANTIPROGESTINS Repros Therapeutics Inc. (US) 2013-01-30 EP disclosed
US-20130018027-A1 COMPOSITIONS AND METHODS FOR NON-TOXIC DELIVERY OF ANTIPROGESTINS REPROS THERAPEUTICS INC. (US) 2013-01-17 US disclosed
WO-2012087389-A1 NOVEL 19-NOR-STEROIDS AND THEIR USE FOR TREATING PROGESTERONE-DEPENDENT CONDITIONS REPROS THERAPEUTICS INC. (US) 2012-06-28 WO disclosed
WO-2011119194-A1 COMPOSITIONS AND METHODS FOR NON-TOXIC DELIVERY OF ANTIPROGESTINS REPROS THERAPEUTICS INC. (US) 2011-09-29 WO disclosed
US-20080200475-A1 4-Piperazinothieno[2,3-D] Pyrimidine Compounds As Platelet Aggregation Inhibitors PFIZER INC. 2008-08-21 US disclosed
EP-1866317-A1 4-PIPERAZINOTHIENO [2, 3-D] PYRIMIDINE COMPOUNDS AS PLATELET AGGREGATION INHIBITORS Pharmacia & Upjohn Company LLC (US) 2007-12-19 EP disclosed
WO-2006103555-A1 4-PIPERAZINOTHIENO [2, 3-D] PYRIMIDINE COMPOUNDS AS PLATELET AGGREGATION INHIBITORS PHARMACIA & UPJOHN COMPANY LLC (US) 2006-10-05 WO disclosed
US-3969392-A PARASITICIDE, BACTERICIDE, ANTIINFLAMMATORY, SURFACTANT E. R. SQUIBB & SONS, INC. (US) 1976-07-13 US disclosed
US-3935230-A α, α, α, α', α', α'-Hexafluorodi-m-tolylamine derivatives E. R. SQUIBB & SONS, INC. (US) 1976-01-27 US disclosed